23.32 USD
-0.54 (-2.26%)
23.32 USD
0 (0%)
Overall PRVA gets a fundamental rating of 4 out of 10. We evaluated PRVA against 102 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for PRVA as it has an excellent financial health rating, but there are worries on the profitability. PRVA is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year PRVA was profitable.
- In the past year PRVA had a positive cash flow from operations.
- The reported net income has been mixed in the past 5 years: PRVA reported negative net income in multiple years.
- PRVA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- PRVA has a Return On Assets of 1.34%. This is comparable to the rest of the industry: PRVA outperforms 53.92% of its industry peers.
- PRVA's Return On Equity of 2.56% is in line compared to the rest of the industry. PRVA outperforms 57.84% of its industry peers.
- PRVA has a Return On Invested Capital (2.45%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROIC | 2.45% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- PRVA has a Profit Margin (0.89%) which is in line with its industry peers.
- PRVA's Profit Margin has declined in the last couple of years.
- With a Operating Margin value of 1.38%, PRVA perfoms like the industry average, outperforming 46.08% of the companies in the same industry.
- PRVA's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 10.17%, PRVA is doing worse than 73.53% of the companies in the same industry.
- In the last couple of years the Gross Margin of PRVA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% |
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRVA is destroying value.
- Compared to 1 year ago, PRVA has more shares outstanding
- Compared to 5 years ago, PRVA has more shares outstanding
- PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- PRVA has an Altman-Z score of 4.44. This indicates that PRVA is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of PRVA (4.44) is better than 80.39% of its industry peers.
- There is no outstanding debt for PRVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.44 |
ROIC/WACC0.27
WACC9.02%
2.3 Liquidity
- A Current Ratio of 1.67 indicates that PRVA should not have too much problems paying its short term obligations.
- PRVA's Current ratio of 1.67 is fine compared to the rest of the industry. PRVA outperforms 64.71% of its industry peers.
- A Quick Ratio of 1.67 indicates that PRVA should not have too much problems paying its short term obligations.
- PRVA has a better Quick ratio (1.67) than 69.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
- PRVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.00%, which is quite impressive.
- PRVA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.43% yearly.
- PRVA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.01%.
- PRVA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.17% yearly.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
3.2 Future
- The Earnings Per Share is expected to grow by 69.05% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 2.73% on average over the next years.
EPS Next Y22%
EPS Next 2Y70.67%
EPS Next 3Y69.05%
EPS Next 5YN/A
Revenue Next Year20.24%
Revenue Next 2Y15.2%
Revenue Next 3Y13.5%
Revenue Next 5Y2.73%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 179.38, PRVA can be considered very expensive at the moment.
- The rest of the industry has a similar Price/Earnings ratio as PRVA.
- PRVA is valuated expensively when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
- A Price/Forward Earnings ratio of 72.78 indicates a quite expensive valuation of PRVA.
- The rest of the industry has a similar Price/Forward Earnings ratio as PRVA.
- When comparing the Price/Forward Earnings ratio of PRVA to the average of the S&P500 Index (24.29), we can say PRVA is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 179.38 | ||
| Fwd PE | 72.78 |
4.2 Price Multiples
- 61.76% of the companies in the same industry are cheaper than PRVA, based on the Enterprise Value to EBITDA ratio.
- PRVA's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.91 | ||
| EV/EBITDA | 65.09 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- PRVA's earnings are expected to grow with 69.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)8.15
PEG (5Y)24.13
EPS Next 2Y70.67%
EPS Next 3Y69.05%
5. Dividend
5.1 Amount
- No dividends for PRVA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
23.32
-0.54 (-2.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners98.68%
Inst Owner Change0.02%
Ins Owners1.85%
Ins Owner Change0%
Market Cap2.87B
Revenue(TTM)2.04B
Net Income(TTM)18.17M
Analysts84.44
Price Target32.18 (37.99%)
Short Float %2.62%
Short Ratio4.03
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.97%
Min EPS beat(2)-60.96%
Max EPS beat(2)-8.97%
EPS beat(4)0
Avg EPS beat(4)-37.14%
Min EPS beat(4)-60.96%
Max EPS beat(4)-8.97%
EPS beat(8)0
Avg EPS beat(8)-42.01%
EPS beat(12)3
Avg EPS beat(12)40.52%
EPS beat(16)6
Avg EPS beat(16)56.54%
Revenue beat(2)2
Avg Revenue beat(2)11.82%
Min Revenue beat(2)5.73%
Max Revenue beat(2)17.91%
Revenue beat(4)4
Avg Revenue beat(4)8.08%
Min Revenue beat(4)0.75%
Max Revenue beat(4)17.91%
Revenue beat(8)8
Avg Revenue beat(8)5.39%
Revenue beat(12)10
Avg Revenue beat(12)0.33%
Revenue beat(16)10
Avg Revenue beat(16)-9.08%
PT rev (1m)0.48%
PT rev (3m)3.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-43.41%
EPS NY rev (1m)0%
EPS NY rev (3m)-19.32%
Revenue NQ rev (1m)-28.31%
Revenue NQ rev (3m)-22.56%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)4.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 179.38 | ||
| Fwd PE | 72.78 | ||
| P/S | 1.4 | ||
| P/FCF | 25.91 | ||
| P/OCF | 25.91 | ||
| P/B | 4.04 | ||
| P/tB | 7.77 | ||
| EV/EBITDA | 65.09 |
EPS(TTM)0.13
EY0.56%
EPS(NY)0.32
Fwd EY1.37%
FCF(TTM)0.9
FCFY3.86%
OCF(TTM)0.9
OCFY3.86%
SpS16.61
BVpS5.77
TBVpS3
PEG (NY)8.15
PEG (5Y)24.13
Graham Number4.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROCE | 3.67% | ||
| ROIC | 2.45% | ||
| ROICexc | 5.77% | ||
| ROICexgc | N/A | ||
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% | ||
| FCFM | 5.42% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-10.22%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
F-Score7
Asset Turnover1.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 112.37 | ||
| Cash Conversion | 296.89% | ||
| Profit Quality | 609.36% | ||
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 4.44 |
F-Score7
WACC9.02%
ROIC/WACC0.27
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
EPS Next Y22%
EPS Next 2Y70.67%
EPS Next 3Y69.05%
EPS Next 5YN/A
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
Revenue Next Year20.24%
Revenue Next 2Y15.2%
Revenue Next 3Y13.5%
Revenue Next 5Y2.73%
EBIT growth 1Y114.42%
EBIT growth 3YN/A
EBIT growth 5Y1.07%
EBIT Next Year573.2%
EBIT Next 3Y111.25%
EBIT Next 5Y64.24%
FCF growth 1Y142.02%
FCF growth 3Y26.09%
FCF growth 5Y42.42%
OCF growth 1Y141.5%
OCF growth 3Y25.67%
OCF growth 5Y35.01%
PRIVIA HEALTH GROUP INC / PRVA FAQ
What is the fundamental rating for PRVA stock?
ChartMill assigns a fundamental rating of 4 / 10 to PRVA.
Can you provide the valuation status for PRIVIA HEALTH GROUP INC?
ChartMill assigns a valuation rating of 2 / 10 to PRIVIA HEALTH GROUP INC (PRVA). This can be considered as Overvalued.
Can you provide the profitability details for PRIVIA HEALTH GROUP INC?
PRIVIA HEALTH GROUP INC (PRVA) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for PRVA stock?
The Price/Earnings (PE) ratio for PRIVIA HEALTH GROUP INC (PRVA) is 179.38 and the Price/Book (PB) ratio is 4.04.
Can you provide the financial health for PRVA stock?
The financial health rating of PRIVIA HEALTH GROUP INC (PRVA) is 7 / 10.